KVK-Tech and Penn Life Sciences name new chief operating officer
15 June 2021 -

KVK-Tech Inc, a company that develops and manufactures high-quality, FDA-approved medicines, and its affiliate Penn Life Sciences Inc announced on Monday that Ram Kamineni has been appointed as chief operating officer.

Kamineni has over 38 years of pharma industry experience. He has served as the SVP, head of Global Operations for Jubilant Pharma, VP, head of Global OSD Manufacturing Strategy for Mylan. He also had various roles in companies such as Novartis, Patheon, and Merck Generics.

KVK and PLS CEO, Anthony Tabasso, was quoted as saying: "We are extremely pleased and excited to welcome Ram as our chief operating officer. With his unique experience and hands-on leadership philosophy, he is an excellent fit. We are confident Ram's knowledge and expertise will further advance our goal to establish our company as a leader in the generics industry. I look forward to working closely with him as we build on our strong foundation to drive sustainable growth, with an emphasis on quality and compliance."